0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biopharmaceuticals Market Size, Status and Forecast 2021-2027
Published Date: June 2021
|
Report Code: QYRE-Auto-22J2409
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Biopharmaceuticals Market Size Status and Forecast 2021 2027

Global Biopharmaceuticals Market Size, Status and Forecast 2021-2027

Code: QYRE-Auto-22J2409
Report
June 2021
109 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures

Biopharmaceuticals Market Analysis - 2027

The global Biopharmaceuticals market was valued at $82330 million in 2020 and is projected to reach $113300 million by 2027, registering a CAGR of 4.7% from 2021 to 2027. A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or maybe living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Biopharmaceuticals Market Analysis

It is costly to discover and develop new drugs/medicines due to expensive research processes, Costs associated with clinical trials, resource-intensive approval procedures and costs associated With manufacturing (if the trials are successful).

Biopharmaceuticals Market Trends

The global population of the elderly is rapidly growing. This rise is propelling the global biopharmaceuticals market size forward, as the elderly population is more susceptible to illness due to poor immunity and long recovery times.

Furthermore, the rising prevalence of chronic diseases as a result of unhealthy lifestyles, poor diets, excessive alcohol intake, and a lack of physical activity are all contributing factors to the rise of biopharmaceutical market size. Many pharmaceutical firms are concentrating their efforts on creating more successful treatments for life-threatening illnesses and encouraging people to live healthy lives with fewer disabilities.

The possibility of side effects associated with certain small-molecule therapeutics and invasive surgical procedures is driving up market demand for biopharmaceuticals. Biopharmaceuticals drugs structurally mimic compounds found within the body and are produced using biotechnologies. These have the potential to cure diseases rather than merely treat symptoms and have fewer side effects because of their specificity. Moreover, because of their efficacy against autoimmune disorders and cancer, as well as their improved mode of action, biopharmaceuticals are expected to replace conventional small molecule drugs in the healthcare industry.

Increasing healthcare investments around the world are precipitating an increase in R&D for biopharmaceuticals. The increased R&D activity is expected to lead to the development of new and more efficient biopharmaceutical products. Thus the increase in healthcare investment is expected to create lucrative growth opportunities for the biopharmaceuticals market.

Biopharmaceuticals Market Segment Review

The Monoclonal Antibodies Segment is expected to be one of the major contributors to the biopharmaceuticals market share. The rapid growth of the segment is due to the active use of monoclonal antibodies and antibody derivatives in therapeutics. Monoclonal antibodies have therapeutic uses in cancer, rheumatoid arthritis, multiple sclerosis, and cardiovascular diseases, among others.

Based on region, North America is expected to be one of the major contributors to the biopharmaceuticals market share. The biopharmaceuticals market in North America is being driven by the rising burden of chronic disease and increased investment in research and development activities in the United States. The United States is known as the world's life sciences innovation capital, and it is active in global capital investments in biopharmaceuticals companies in their early stages.

Biopharmaceuticals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Biopharmaceuticals Market by Type

  • Monoclonal Antibodies
  • Interferon
  • Colony-Stimulating Factor
  • Erythropoietin
  • Insulin
  • Vaccines
  • Growth Hormones
  • Others

Biopharmaceuticals Market by Application

  • Tumor
  • Diabetes
  • Cardiovascular
  • Hemophilia
  • Others

Biopharmaceuticals Market by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Major Players in the Biopharmaceuticals Market

  • Roche
  • Amgen
  • AbbVie
  • Sanofi-Aventis
  • Johnson & Johnson
  • Pfizer
  • Novo Nordisk
  • Eli Lilly
  • Novartis
  • Merck

Biopharmaceuticals Market Report Coverage

Report Metric

Details

Base Year:

2020

Market Size in 2020:

USD 82330 Million

Forecast Period:

2021 to 2027

Forecast Period 2021 to 2027 CAGR:

4.7%

Largest Market

North America

2027 Value Projection:

USD 113300 Million

No. of Pages:

109

Tables & Figures

132

Segments covered:

Type, Application, Region

Frequently Asked Questions About This Report

1. What will be the global Biopharmaceuticals Market size from 2020 to 2027?

Ans. The global Biopharmaceuticals market was valued at $82330 million in 2020 and is projected to reach $113300 million by 2027

2. What is the growth rate of the global Biopharmaceuticals Market during the forecast period?

Ans. The global Biopharmaceuticals market is estimated to grow with a CAGR of 4.7% during the forecast period

3. What are the upcoming trends or opportunities in the Biopharmaceuticals market?

Ans. Growing geriatric population, rising chronic diseases, and increasing acceptance in the healthcare industry.

4. Who are the top companies hold the market share in the Biopharmaceuticals market?

Ans. Major companies across the market are Roche, Amgen Inc, AbbVie, Sanofi Aventis, Johnson & Johnson, Pfizer Inc, Novo Nordisk, Eli Lilly, Novartis, Merck, World Health Organization, Others are positively contributing to the global market forecast.

5. Does the report provide COVID-19 impact analysis?

Ans. Yes, the report includes a COVID-19 impact analysis. Also, it is further extended into every individual segment of the report.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceuticals Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Colony-Stimulating Factor
1.2.5 Erythropoietin
1.2.6 Insulin
1.2.7 Vaccines
1.2.8 Growth Hormones
1.2.9 Others
1.3 Market by Application
1.3.1 Global Biopharmaceuticals Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceuticals Market Perspective (2016-2027)
2.2 Biopharmaceuticals Growth Trends by Regions
2.2.1 Biopharmaceuticals Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biopharmaceuticals Historic Market Share by Regions (2016-2021)
2.2.3 Biopharmaceuticals Forecasted Market Size by Regions (2022-2027)
2.3 Biopharmaceuticals Industry Dynamic
2.3.1 Biopharmaceuticals Market Trends
2.3.2 Biopharmaceuticals Market Drivers
2.3.3 Biopharmaceuticals Market Challenges
2.3.4 Biopharmaceuticals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceuticals Players by Revenue
3.1.1 Global Top Biopharmaceuticals Players by Revenue (2016-2021)
3.1.2 Global Biopharmaceuticals Revenue Market Share by Players (2016-2021)
3.2 Global Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceuticals Revenue
3.4 Global Biopharmaceuticals Market Concentration Ratio
3.4.1 Global Biopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceuticals Revenue in 2020
3.5 Biopharmaceuticals Key Players Head office and Area Served
3.6 Key Players Biopharmaceuticals Product Solution and Service
3.7 Date of Enter into Biopharmaceuticals Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceuticals Breakdown Data by Type
4.1 Global Biopharmaceuticals Historic Market Size by Type (2016-2021)
4.2 Global Biopharmaceuticals Forecasted Market Size by Type (2022-2027)
5 Biopharmaceuticals Breakdown Data by Application
5.1 Global Biopharmaceuticals Historic Market Size by Application (2016-2021)
5.2 Global Biopharmaceuticals Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Biopharmaceuticals Market Size (2016-2027)
6.2 North America Biopharmaceuticals Market Size by Type
6.2.1 North America Biopharmaceuticals Market Size by Type (2016-2021)
6.2.2 North America Biopharmaceuticals Market Size by Type (2022-2027)
6.2.3 North America Biopharmaceuticals Market Size by Type (2016-2027)
6.3 North America Biopharmaceuticals Market Size by Application
6.3.1 North America Biopharmaceuticals Market Size by Application (2016-2021)
6.3.2 North America Biopharmaceuticals Market Size by Application (2022-2027)
6.3.3 North America Biopharmaceuticals Market Size by Application (2016-2027)
6.4 North America Biopharmaceuticals Market Size by Country
6.4.1 North America Biopharmaceuticals Market Size by Country (2016-2021)
6.4.2 North America Biopharmaceuticals Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Biopharmaceuticals Market Size (2016-2027)
7.2 Europe Biopharmaceuticals Market Size by Type
7.2.1 Europe Biopharmaceuticals Market Size by Type (2016-2021)
7.2.2 Europe Biopharmaceuticals Market Size by Type (2022-2027)
7.2.3 Europe Biopharmaceuticals Market Size by Type (2016-2027)
7.3 Europe Biopharmaceuticals Market Size by Application
7.3.1 Europe Biopharmaceuticals Market Size by Application (2016-2021)
7.3.2 Europe Biopharmaceuticals Market Size by Application (2022-2027)
7.3.3 Europe Biopharmaceuticals Market Size by Application (2016-2027)
7.4 Europe Biopharmaceuticals Market Size by Country
7.4.1 Europe Biopharmaceuticals Market Size by Country (2016-2021)
7.4.2 Europe Biopharmaceuticals Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceuticals Market Size (2016-2027)
8.2 Asia-Pacific Biopharmaceuticals Market Size by Type
8.2.1 Asia-Pacific Biopharmaceuticals Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biopharmaceuticals Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biopharmaceuticals Market Size by Type (2016-2027)
8.3 Asia-Pacific Biopharmaceuticals Market Size by Application
8.3.1 Asia-Pacific Biopharmaceuticals Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biopharmaceuticals Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biopharmaceuticals Market Size by Application (2016-2027)
8.4 Asia-Pacific Biopharmaceuticals Market Size by Region
8.4.1 Asia-Pacific Biopharmaceuticals Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biopharmaceuticals Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biopharmaceuticals Market Size (2016-2027)
9.2 Latin America Biopharmaceuticals Market Size by Type
9.2.1 Latin America Biopharmaceuticals Market Size by Type (2016-2021)
9.2.2 Latin America Biopharmaceuticals Market Size by Type (2022-2027)
9.2.3 Latin America Biopharmaceuticals Market Size by Type (2016-2027)
9.3 Latin America Biopharmaceuticals Market Size by Application
9.3.1 Latin America Biopharmaceuticals Market Size by Application (2016-2021)
9.3.2 Latin America Biopharmaceuticals Market Size by Application (2022-2027)
9.3.3 Latin America Biopharmaceuticals Market Size by Application (2016-2027)
9.4 Latin America Biopharmaceuticals Market Size by Country
9.4.1 Latin America Biopharmaceuticals Market Size by Country (2016-2021)
9.4.2 Latin America Biopharmaceuticals Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceuticals Market Size (2016-2027)
10.2 Middle East & Africa Biopharmaceuticals Market Size by Type
10.2.1 Middle East & Africa Biopharmaceuticals Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biopharmaceuticals Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biopharmaceuticals Market Size by Type (2016-2027)
10.3 Middle East & Africa Biopharmaceuticals Market Size by Application
10.3.1 Middle East & Africa Biopharmaceuticals Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biopharmaceuticals Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biopharmaceuticals Market Size by Application (2016-2027)
10.4 Middle East & Africa Biopharmaceuticals Market Size by Country
10.4.1 Middle East & Africa Biopharmaceuticals Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biopharmaceuticals Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Biopharmaceuticals Introduction
11.1.4 Roche Revenue in Biopharmaceuticals Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Biopharmaceuticals Introduction
11.2.4 Amgen Revenue in Biopharmaceuticals Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Biopharmaceuticals Introduction
11.3.4 AbbVie Revenue in Biopharmaceuticals Business (2016-2021)
11.3.5 AbbVie Recent Development
11.4 Sanofi-Aventis
11.4.1 Sanofi-Aventis Company Details
11.4.2 Sanofi-Aventis Business Overview
11.4.3 Sanofi-Aventis Biopharmaceuticals Introduction
11.4.4 Sanofi-Aventis Revenue in Biopharmaceuticals Business (2016-2021)
11.4.5 Sanofi-Aventis Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Biopharmaceuticals Introduction
11.5.4 Johnson & Johnson Revenue in Biopharmaceuticals Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Biopharmaceuticals Introduction
11.6.4 Pfizer Revenue in Biopharmaceuticals Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Details
11.7.2 Novo Nordisk Business Overview
11.7.3 Novo Nordisk Biopharmaceuticals Introduction
11.7.4 Novo Nordisk Revenue in Biopharmaceuticals Business (2016-2021)
11.7.5 Novo Nordisk Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Biopharmaceuticals Introduction
11.8.4 Eli Lilly Revenue in Biopharmaceuticals Business (2016-2021)
11.8.5 Eli Lilly Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Biopharmaceuticals Introduction
11.9.4 Novartis Revenue in Biopharmaceuticals Business (2016-2021)
11.9.5 Novartis Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Biopharmaceuticals Introduction
11.10.4 Merck Revenue in Biopharmaceuticals Business (2016-2021)
11.10.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Biopharmaceuticals Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Monoclonal Antibodies
    Table 3. Key Players of Interferon
    Table 4. Key Players of Colony-Stimulating Factor
    Table 5. Key Players of Erythropoietin
    Table 6. Key Players of Insulin
    Table 7. Key Players of Vaccines
    Table 8. Key Players of Growth Hormones
    Table 9. Key Players of Others
    Table 10. Global Biopharmaceuticals Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 11. Global Biopharmaceuticals Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 12. Global Biopharmaceuticals Market Size by Regions (2016-2021) & (US$ Million)
    Table 13. Global Biopharmaceuticals Market Share by Regions (2016-2021)
    Table 14. Global Biopharmaceuticals Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 15. Global Biopharmaceuticals Market Share by Regions (2022-2027)
    Table 16. Biopharmaceuticals Market Trends
    Table 17. Biopharmaceuticals Market Drivers
    Table 18. Biopharmaceuticals Market Challenges
    Table 19. Biopharmaceuticals Market Restraints
    Table 20. Global Biopharmaceuticals Revenue by Players (2016-2021) & (US$ Million)
    Table 21. Global Biopharmaceuticals Market Share by Players (2016-2021)
    Table 22. Global Top Biopharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceuticals as of 2020)
    Table 23. Ranking of Global Top Biopharmaceuticals Companies by Revenue (US$ Million) in 2020
    Table 24. Global 5 Largest Players Market Share by Biopharmaceuticals Revenue (CR5 and HHI) & (2016-2021)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players Biopharmaceuticals Product Solution and Service
    Table 27. Date of Enter into Biopharmaceuticals Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)
    Table 30. Global Biopharmaceuticals Revenue Market Share by Type (2016-2021)
    Table 31. Global Biopharmaceuticals Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 32. Global Biopharmaceuticals Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 33. Global Biopharmaceuticals Market Size Share by Application (2016-2021) & (US$ Million)
    Table 34. Global Biopharmaceuticals Revenue Market Share by Application (2016-2021)
    Table 35. Global Biopharmaceuticals Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 36. Global Biopharmaceuticals Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 37. North America Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)
    Table 38. North America Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
    Table 39. North America Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)
    Table 40. North America Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
    Table 41. North America Biopharmaceuticals Market Size by Country (2016-2021) & (US$ Million)
    Table 42. North America Biopharmaceuticals Market Size by Country (2022-2027) & (US$ Million)
    Table 43. Europe Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)
    Table 44. Europe Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Europe Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)
    Table 46. Europe Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Europe Biopharmaceuticals Market Size by Country (2016-2021) & (US$ Million)
    Table 48. Europe Biopharmaceuticals Market Size by Country (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)
    Table 50. Asia-Pacific Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Asia-Pacific Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)
    Table 52. Asia-Pacific Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Asia-Pacific Biopharmaceuticals Market Size by Region (2016-2021) & (US$ Million)
    Table 54. Asia-Pacific Biopharmaceuticals Market Size by Region (2022-2027) & (US$ Million)
    Table 55. Latin America Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)
    Table 56. Latin America Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Latin America Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)
    Table 58. Latin America Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Latin America Biopharmaceuticals Market Size by Country (2016-2021) & (US$ Million)
    Table 60. Latin America Biopharmaceuticals Market Size by Country (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)
    Table 62. Middle East & Africa Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
    Table 63. Middle East & Africa Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)
    Table 64. Middle East & Africa Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
    Table 65. Middle East & Africa Biopharmaceuticals Market Size by Country (2016-2021) & (US$ Million)
    Table 66. Middle East & Africa Biopharmaceuticals Market Size by Country (2022-2027) & (US$ Million)
    Table 67. Roche Company Details
    Table 68. Roche Business Overview
    Table 69. Roche Biopharmaceuticals Product
    Table 70. Roche Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 71. Roche Recent Development
    Table 72. Amgen Company Details
    Table 73. Amgen Business Overview
    Table 74. Amgen Biopharmaceuticals Product
    Table 75. Amgen Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 76. Amgen Recent Development
    Table 77. AbbVie Company Details
    Table 78. AbbVie Business Overview
    Table 79. AbbVie Biopharmaceuticals Product
    Table 80. AbbVie Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 81. AbbVie Recent Development
    Table 82. Sanofi-Aventis Company Details
    Table 83. Sanofi-Aventis Business Overview
    Table 84. Sanofi-Aventis Biopharmaceuticals Product
    Table 85. Sanofi-Aventis Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 86. Sanofi-Aventis Recent Development
    Table 87. Johnson & Johnson Company Details
    Table 88. Johnson & Johnson Business Overview
    Table 89. Johnson & Johnson Biopharmaceuticals Product
    Table 90. Johnson & Johnson Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 91. Johnson & Johnson Recent Development
    Table 92. Pfizer Company Details
    Table 93. Pfizer Business Overview
    Table 94. Pfizer Biopharmaceuticals Product
    Table 95. Pfizer Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 96. Pfizer Recent Development
    Table 97. Novo Nordisk Company Details
    Table 98. Novo Nordisk Business Overview
    Table 99. Novo Nordisk Biopharmaceuticals Product
    Table 100. Novo Nordisk Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 101. Novo Nordisk Recent Development
    Table 102. Eli Lilly Company Details
    Table 103. Eli Lilly Business Overview
    Table 104. Eli Lilly Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 105. Eli Lilly Recent Development
    Table 106. Novartis Company Details
    Table 107. Novartis Business Overview
    Table 108. Novartis Biopharmaceuticals Product
    Table 109. Novartis Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 110. Novartis Recent Development
    Table 111. Merck Company Details
    Table 112. Merck Business Overview
    Table 113. Merck Biopharmaceuticals Product
    Table 114. Merck Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 115. Merck Recent Development
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Biopharmaceuticals Market Share by Type: 2020 VS 2027
    Figure 2. Monoclonal Antibodies Features
    Figure 3. Interferon Features
    Figure 4. Colony-Stimulating Factor Features
    Figure 5. Erythropoietin Features
    Figure 6. Insulin Features
    Figure 7. Vaccines Features
    Figure 8. Growth Hormones Features
    Figure 9. Others Features
    Figure 10. Global Biopharmaceuticals Market Share by Application: 2020 VS 2027
    Figure 11. Tumor Case Studies
    Figure 12. Diabetes Case Studies
    Figure 13. Cardiovascular Case Studies
    Figure 14. Hemophilia Case Studies
    Figure 15. Others Case Studies
    Figure 16. Biopharmaceuticals Report Years Considered
    Figure 17. Global Biopharmaceuticals Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 18. Global Biopharmaceuticals Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 19. Global Biopharmaceuticals Market Share by Regions: 2020 VS 2027
    Figure 20. Global Biopharmaceuticals Market Share by Regions (2022-2027)
    Figure 21. Global Biopharmaceuticals Market Share by Players in 2020
    Figure 22. Global Top Biopharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceuticals as of 2020
    Figure 23. The Top 10 and 5 Players Market Share by Biopharmaceuticals Revenue in 2020
    Figure 24. Global Biopharmaceuticals Revenue Market Share by Type (2016-2021)
    Figure 25. Global Biopharmaceuticals Revenue Market Share by Type (2022-2027)
    Figure 26. North America Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. North America Biopharmaceuticals Market Share by Type (2016-2027)
    Figure 28. North America Biopharmaceuticals Market Share by Application (2016-2027)
    Figure 29. North America Biopharmaceuticals Market Share by Country (2016-2027)
    Figure 30. United States Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Canada Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Europe Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Europe Biopharmaceuticals Market Share by Type (2016-2027)
    Figure 34. Europe Biopharmaceuticals Market Share by Application (2016-2027)
    Figure 35. Europe Biopharmaceuticals Market Share by Country (2016-2027)
    Figure 36. Germany Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. France Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. U.K. Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Italy Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Russia Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Nordic Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Asia-Pacific Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Asia-Pacific Biopharmaceuticals Market Share by Type (2016-2027)
    Figure 44. Asia-Pacific Biopharmaceuticals Market Share by Application (2016-2027)
    Figure 45. Asia-Pacific Biopharmaceuticals Market Share by Region (2016-2027)
    Figure 46. China Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Japan Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. South Korea Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Southeast Asia Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. India Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Australia Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Latin America Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Latin America Biopharmaceuticals Market Share by Type (2016-2027)
    Figure 54. Latin America Biopharmaceuticals Market Share by Application (2016-2027)
    Figure 55. Latin America Biopharmaceuticals Market Share by Country (2016-2027)
    Figure 56. Mexico Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Brazil Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Middle East & Africa Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Middle East & Africa Biopharmaceuticals Market Share by Type (2016-2027)
    Figure 60. Middle East & Africa Biopharmaceuticals Market Share by Application (2016-2027)
    Figure 61. Middle East & Africa Biopharmaceuticals Market Share by Country (2016-2027)
    Figure 62. Turkey Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 63. Saudi Arabia Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 64. UAE Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 65. Roche Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 66. Amgen Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 67. AbbVie Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 68. Sanofi-Aventis Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 69. Johnson & Johnson Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 70. Pfizer Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 71. Novo Nordisk Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 72. Eli Lilly Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 73. Novartis Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 74. Merck Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Novocure

RELATED REPORTS

Global and United States Biologics Drug Development Market Report Forecast 2022 2028
Global and United States Biologics Drug Development Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-5X6010
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Biologics Drug Discovery Market Report Forecast 2022 2028
Global and United States Biologics Drug Discovery Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-0D6239
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Nanopharmaceutical Drugs Market Report Forecast 2022 2028
Global and United States Nanopharmaceutical Drugs Market Report & Forecast 2022-2028

The increasing prevalence of chronic diseases and development of the healthcare infrastructure are promoting the adoption of the novel medicine known as nanomedicine for better efficacy and improved patient outcome.Market Analysis and Insights Global and United States Nanopharmaceutical Drugs MarketThis report focuses on global and United States Nanopharmaceutical Drugs market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Nanopharmaceutical Drugs market size is estimated to be worth US 35330 million in 2022 and is forecast to a readjusted size of US 72540 million by 2028 with a CAGR of 12.7 during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-24J10248
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Polymerase Chain Reaction Technology Market Report Forecast 2022 2028
Global and United States Polymerase Chain Reaction Technology Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-7I6111
Tue Jun 07 00:00:00 UTC 2022

Add to Cart